Body fat distribution and risk of premenopausal breast cancer in the nurses' health study II

Journal of the National Cancer Institute

Volumn 103, Issue 3, 2011, Pages 273-278

  Harris, Holly R ^a,b   Willett, Walter C ^a,c   Terry, Kathryn L ^a,b,c   Michels, Karin B ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Obstetrics and Gynecology Epidemiology Center   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ADULT; BODY FAT DISTRIBUTION; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NURSES; PREMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 79551711062     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq500     Document Type: Article

References (61)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: American Institute for Cancer Research; 2007;289.
2. Brinton LA, Swanson CA. Height and weight at various ages and risk of breast cancer. Ann Epidemiol. 1992;2(5):597-609.
3. Bruning P, Bonfrer J, Hart A, Noord PV, Hoeven HVD, Collette H. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer. 1992;51(1):14-19.
4. Franceschi S, Favero A, La Vecchia C, et al. Body size indices and breast (Pubitemid 26274146)
5. Harris RE, Namboodiri KK, Wynder EL. Breast cancer risk: effects of estrogen replacement therapy and body mass. J Natl Cancer Inst. 1992;84(20):1575-1582.
6. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278(17):1407-1411. (Pubitemid 27475968)
7. Kaaks R, Noord PAHV, Tonkelaar ID, Peeters PHM, Riboli E, Grobbee DE. Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch "DOM" cohort. Int J Cancer. 1998;76(5):647-651. (Pubitemid 28243935)
8. Lahmann P, Lissner L, Gullberg B, Olsson H, Berglund G. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmö diet and cancer study. Int J Cancer. 2003;103(2):246-252. (Pubitemid 35461518)
9. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2004;111(5):762-771. (Pubitemid 39062901)
10. Le Marchand L, Kolonel LN, Earle ME, Mi M-P. Body size at different periods of life and breast cancer risk. Am J Epidemiol. 1988;128(1):137-152.
11. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395-2402. (Pubitemid 44833368)
12. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control. 2002;13(8):741-751. (Pubitemid 35204050)
13. Sonnenschein E, Toniolo P, Terry MB, et al. Body fat distribution and obesity in pre-and postmenopausal breast cancer. Int J Epidemiol. 1999;28(6):1026-1031. (Pubitemid 30021299)
14. Tehard B, Lahmann P, Riboli E, Clavel-Chapelon F. Anthropometry, breast cancer and menopausal status: use of repeated measurements over 10 years of follow-up-results of the French E3N women's cohort study. Int J Cancer. 2004;111(2):264-269. (Pubitemid 38924705)
15. Van den Brandt PA, Spiegelman D, Yaun S-S, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514-527.
16. Vatten LJ, Kvinnsland S. Prospective study of height, body mass index and risk of breast cancer. Acta Oncologica. 1992;31(2):195-200.
17. Weiderpass E, Braaten T, Magnusson C, et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(7):1121-1127. (Pubitemid 38917900)
18. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10(1):15-32. (Pubitemid 32200199)
19. Tehard B, Clavel-Chapelon F. Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obes Relat Metab Disord. 2005;30(1):156-163.
20. Bouchardy C, Lê MG, Hill C. Risk factors for breast cancer according to age at diagnosis in a French case-control study. J Clin Epidemiol. 1990;43(3):267-275. (Pubitemid 20074211)
21. Clavel F, Andrieu N, Gairard B, et al. Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol. 1991;20(1):32-38.
22. Hu Y-H, Nagata C, Shimizu H, Kaneda N, Kashiki Y. Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat. 1997;43(1):65-72. (Pubitemid 27090868)
23. London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE. Prospective study of relative weight, height, and risk of breast cancer. JAMA. 1989;262(20):2853-2858. (Pubitemid 20002545)
24. Swanson CA, Brinton LA, Taylor PR, Licitra LM, Ziegler RG, Schairer C. Body size and breast cancer risk assessed in women participating in the breast cancer detection demonstration project. Am J Epidemiol. 1989;130(6):1133-1141. (Pubitemid 20016350)
25. Tournberg SA, Holm LE, Carstensen JM. Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncologica. 1988;27(1):31-37.
26. Tretli S. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer. 1989;44(1):23-30. (Pubitemid 19184671)
27. Vatten L, Kvinnsland S. Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer. 1990;45(3):440-444. (Pubitemid 20087189)
28. Willett WC, Browne ML, Bain C, et al. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol. 1985;122(5):731-740. (Pubitemid 16207339)
29. Amemiya T, Kawahara R, Yoshino M, Komori K, Hirata Y. Population study on the adipose tissue distribution in Japanese women born in 1948. Diabetes Res Clin Pract. 1990;10(suppl 1):S71-S76. (Pubitemid 20315101)
30. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int. J. Epidemiol. 1991;20(1):151-156.
31. Seidell JC, Cigolini M, Charzewska J, et al. Androgenicity in relation to body fat distribution and metabolism in 38-year-old women-the European fat distribution study. J Clin Epidemiol. 1990;43(1):21-34. (Pubitemid 20036962)
32. Seidell JC, Cigolini M, Deurenberg P, Oosterlee A, Doornbos G. Fat distribution, androgens, and metabolism in nonobese women. Am J Clin Nutr. 1989;50(2):269-273. (Pubitemid 19208742)
33. Haffner S, Katz M, Stern M, Dunn J. Relationship of sex hormone globulin to overall adiposity and body fat distribution in a biethnic population. Int J Obes. 1989;13(1):1-9. (Pubitemid 19060098)
34. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obesity Rev. 2003;4(3):157-173. (Pubitemid 36950578)
35. Kirschner M, Samojlik E, Drejka M, Szmal E, Schneider G, Ertel N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab. 1990;70(2):473-479.
36. Bruning P, Bonfrer J, Moord PV, Hart A, DeJong-Bakker M, Nooijen W. Insulin resistance and breast cancer risk. Int J Cancer. 1992;52(4):511-516.
37. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006;98(19):1406-1415. (Pubitemid 44530717)
38. DelGiudice M, Fantus I, Ezzat S, McKeown-Eyssen G, Page D, Goodwin P. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat. 1998;47(2):111-120. (Pubitemid 28046082)
39. Sieri S, Pala V, Brighenti F, et al. Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study. Am J Clin Nutr. 2007;86(4):1160-1166. (Pubitemid 47538322)
40. Huang Z, Willett WC, Colditz GA, et al. Waist circumference, waist: hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol. 1999;150(12):1316-1324.
41. Muti P, Stanulla M, Micheli A, et al. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy). Cancer Causes Control. 2000;11(8):721-730.
42. Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1795-1802. (Pubitemid 47450509)
43. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278(13):1078-1083. (Pubitemid 27418334)
44. Collins LC, Marotti JD, Baer HJ, Tamimi RM. Comparison of estrogen receptor results from pathology reports with results from central labaratory testing. J Natl Cancer Inst. 2008;100(3):218-221. (Pubitemid 351480544)
45. Greenland S. Problems in the average-risk interpretation of categorical dose-response analyses. Epidemiology. 1995;6(5):563-565.
46. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51(2):524-532.
47. Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer. 2002;44(2):127-138. (Pubitemid 36637941)
48. Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer. 1996;68(1):8-13. (Pubitemid 26354570)
49. Huang W-Y, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151(7):703-714. (Pubitemid 30463592)
50. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86(3):823S-835S.
51. Mulligan A, O'Malley F, Ennis M, Fantus I, Goodwin P. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat. 2007;106(1):39-47. (Pubitemid 47498088)
52. Chappell J, Leitner JW, Solomon S, Golovchenko I, Goalstone ML, Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. J Biol Chem. 2001;276(41):38023-38028.
53. Milazzo G, Giorgino F, Damante G, et al. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res. 1992;52(14):3924-3930.
54. Osborne CK, Monaco ME, Lippman ME, Kahn CR. Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture. Cancer Res. 1978;38(1):94-102. (Pubitemid 8253520)
55. Van der Burg B, Rutteman GR, Blankenstein MA, De Laat SW, Van Zoelen EJ. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol. 1988;134(1):101-108. (Pubitemid 18034935)
56. Cullen KJ, Yee D, Sly WS, et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 1990;50(1):48-53. (Pubitemid 20029992)
57. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96(3):218-228. (Pubitemid 38263181)
58. Willett W. Nutritional Epidemiology. 2 ed. Oxford, UK: Oxford University Press; 1998.
59. Rimm E, Stampfer M, Colditz G, Chute C, Litin L, Willett W. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1(6):466-473.
60. Thomas D, Stram D, Dwyer J. Exposure measurement error: influence on exposure-disease. Relationships and methods of correction. Annu Rev Public Health. 1993;14(1):69-93. (Pubitemid 23161712)
61. Soto González A, Bellido D, Buño MM, et al. Predictors of the metabolic syndrome and correlation with computed axial tomography. Nutrition. 2007;23(1):36-45. (Pubitemid 44959772)